Microsystems technologies for drug delivery to the inner ear

---

Authors:

• Erin E. Leary Pararas^a,
• David A. Borkholder^b,
• Jeffrey T. Borenstein^{a, ,}

• ^a Charles Stark Draper Laboratory, 555 Technology Square, Cambridge, MA 02139, USA
• ^b Rochester Institute of Technology, Department of Electrical and Microelectronic Engineering, 79 Lomb Memorial Drive, Rochester, NY 14623, USA

Abstract

The inner ear represents one of the most technologically challenging targets for local drug delivery, but its clinical significance is rapidly increasing. 

The prevalence of sensorineural hearing loss and other auditory diseases, along with balance disorders and tinnitus, has spurred broad efforts to develop therapeutic compounds and regenerative approaches to treat these conditions, necessitating advances in systems capable of targeted and sustained drug delivery. 

The delicate nature of hearing structures combined with the relative inaccessibility of the cochlea by means of conventional delivery routes together necessitate significant advancements in both the precision and miniaturization of delivery systems, and the nature of the molecular and cellular targets for these therapies suggests that multiple compounds may need to be delivered in a time-sequenced fashion over an extended duration. 

Here we address the various approaches being developed for inner ear drug delivery, including micropump-based devices, reciprocating systems, and cochlear prosthesis-mediated delivery, concluding with an analysis of emerging challenges and opportunities for the first generation of technologies suitable for human clinical use. 

These developments represent exciting advances that have the potential to repair and regenerate hearing structures in millions of patients for whom no currently available medical treatments exist, a situation that requires them to function with electronic hearing augmentation devices or to live with severely impaired auditory function. 

These advances also have the potential for broader clinical applications that share similar requirements and challenges with the inner ear, such as drug delivery to the central nervous system.

---

Graphical abstract

Figure options

Keywords

---

Figures and tables from this article:

Fig. 1. (a.) A mid-modiolar section from a human temporal bone indicates the coiled structure of the cochlea as it winds around a central modiolius. Each segment (b.) contains 3 fluid filled structures, the scala tympani (ST) scala media (SM) and scala vestibuli (SV). The organ of Corti (OC) is shown at the base of the SM.

Used with permission from Elsevier [47].

Figure options

Fig. 2. a. A schematic drawing of the reciprocating delivery system showing the flexible membrane and actuator. b. Photograph of wearable device for guinea pig studies. The device measures 5.5 × 4.0 × 3.8 cm.

Used with permission from Karger AG Basel and Springer  and .

Figure options

Fig. 3. CAP threshold shifts due to DNQX delivery at various frequencies. Three flow rate profiles are shown with higher flow rates causing increased threshold rises. Multiple experiments for each flow rate are shown.

Used with permission from Elsevier [56].

Figure options

Fig. 4. Theoretical flow path within the cochlea and vestibular system for a cochleostomy-only infusion (green), and a cochleostomy-plus-canalostomy perfusion (red). Pressure driven flow is depicted with solid lines while dotted lines represent diffusion mechanisms. Cochlear aqueduct (ca); scala tympani (st), scala vestibuli (sv). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Used with permission from Elsevier [9].

Figure options

Fig. 5. Frequency dependent DPOAE threshold shifts. Surgery and infusion of artificial perilymph had insignificant impact on thresholds, while frequency dependent threshold shifts were observed with 10 mM salicylate. Statistical comparison of peak threshold shifts to baseline for each frequency and each surgical approach is shown in the figure (*p < 0.05, **p < 0.01, ***p < 0.001). Data are plotted as mean ± SEM (n = 8 animals for each approach).

Used with permission from Elsevier [9].

Figure options

Fig. 6. Illustration of drug delivery enabled by laser-drilled holes of 50 μm diameter to enable enhanced drug distribution in the cochlea.

Used with permission from Elsevier [64].

Fig. 8. SEM of the side of the microfluidic chip with small diameter (140-μm OD) tubing exiting in-plane.

Used with permission from IEEE [67].

Corresponding author.

• Fuente:

• Advanced Drug Delivery Reviews
• http://dx.doi.org/10.1016/j.addr.2012.02.004,